Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance.
about
Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes.The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failureCurrent therapy of myelodysplastic syndromesAntiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.Etiological causes of pancytopenia: A report of 137 cases.The genetic basis of myelodysplasia and its clinical relevanceImmunological derangement in hypocellular myelodysplastic syndromes.Myelodysplastic syndromes: toward a risk-adapted treatment approach.Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.MDS and GCA: a prognostic dilemma.Rheumatic manifestations and an epipharyngeal mass accompanied by myelodysplastic syndrome.Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment.Low C3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis.Paraneoplastic large vessel arteritis complicating myelodysplastic syndrome.
P2860
Q33442617-35DC6BE2-3D84-4481-8009-D4176B1C0C6BQ33829778-CAD57E40-4C1F-466D-814B-EFE9B216842DQ34013796-286513F4-2B39-4F10-BE15-C887FE1316FAQ34244151-A808193D-8BCA-40B8-983E-4447C1B9B495Q35049152-188BF301-34C7-4C17-AC40-C97D93558273Q35214418-F1B0102F-B785-4723-B4C0-07DCEE100D78Q35571031-BA3F2C5C-4918-429A-929C-F34042781520Q37319789-ED70977F-E660-4191-9191-D8A046E94636Q37390236-31101AA5-535F-41A1-92F1-3390FC137593Q37724605-3EE1870E-FB95-44B9-8F79-3E1C79F288F1Q38149315-7F60AD63-4897-43F5-9C50-98AA2E5E6969Q38196461-CCCC9726-8B42-4A5C-B44B-8ECA4379C037Q38529556-3838ABB1-C751-48F9-9469-7E407676BCA5Q40225798-5647A9CC-8113-4102-88E5-B1220E060A3DQ42922539-235F1F48-1CED-4A6C-8059-A948EC486072Q45790469-B92FF6B1-E391-4407-AC37-6A6B3734A971Q53181995-2BD6A687-E1F8-4D5C-B375-CBC809C75742
P2860
Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmune mechanisms in the p ...... and their clinical relevance.
@en
Autoimmune mechanisms in the p ...... and their clinical relevance.
@nl
type
label
Autoimmune mechanisms in the p ...... and their clinical relevance.
@en
Autoimmune mechanisms in the p ...... and their clinical relevance.
@nl
prefLabel
Autoimmune mechanisms in the p ...... and their clinical relevance.
@en
Autoimmune mechanisms in the p ...... and their clinical relevance.
@nl
P2860
P1433
P1476
Autoimmune mechanisms in the p ...... and their clinical relevance.
@en
P2093
A John Barrett
Elaine Sloand
P2860
P304
P356
10.3324/HAEMATOL.2009.006080
P577
2009-04-01T00:00:00Z